Viatris

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Viatris (VTRS) Q2 2026 Earnings Call Transcript (öffnet in neuem Tab)

  Fortune · 01.10.2026

• Viatris Inc. stock falls Wednesday, underperforms market (öffnet in neuem Tab)

  MarketWatch · 30.09.2026

• Viatris Inc. (VTRS) Stock Price, News, Quote & History (öffnet in neuem Tab)

  Yahoo! Finance Canada · 30.09.2026

• Viatris Facing Multiple Paths to Earnings Growth, Oppenheimer Says (öffnet in neuem Tab)

  Moomoo · 30.09.2026

• Net income before discontinued operations of Viatris, Inc. – HAN:VIA (öffnet in neuem Tab)

  TradingView · 30.09.2026

• Viatris named to Forbes' World's Best Employers list for sixth year, highlighting strong workplace culture. (öffnet in neuem Tab)

  Pluang · 29.09.2026

• Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year (öffnet in neuem Tab)

  PR Newswire · 29.09.2026

• Viatris stock hits 52-week high at 18.4 USD (öffnet in neuem Tab)

  Investing.com · 29.09.2026

• Will Japan WAKIX Approval Change Viatris (VTRS) Stock Narrative (öffnet in neuem Tab)

  Simply Wall Street · 28.09.2026

• Viatris Inc. stock rises Monday, outperforms market (öffnet in neuem Tab)

  MarketWatch · 28.09.2026

• Is Viatris (VTRS) Cheap On Its Japan WAKIX Approval? (öffnet in neuem Tab)

  Simply Wall Street · 27.09.2026

• Viatris (VTRS) Q1 2026 Earnings Call Transcript (öffnet in neuem Tab)

  Fortune · 26.09.2026

• Viatris Inc. (VTRS) stock price, news, quote and history (öffnet in neuem Tab)

  Yahoo Finance Singapore · 26.09.2026

• Viatris Inc. stock rises Friday, outperforms market (öffnet in neuem Tab)

  MarketWatch · 25.09.2026

• Viatris sues Novo Nordisk, seeks to market generic Wegovy (öffnet in neuem Tab)

  Seeking Alpha · 25.09.2026

• Viatris sues Novo Nordisk over generic Wegovy patent dispute (öffnet in neuem Tab)

  Yahoo Finance · 25.09.2026

• Viatris Appoints Joe Paul Philip to Lead Manufacturing Science and Technology in Three Markets (öffnet in neuem Tab)

  konsulteer.com · 25.09.2026

• Is Viatris Stock Outperforming the S&P 500? (öffnet in neuem Tab)

  Yahoo Finance · 24.09.2026

• How Viatris Inc. (VTRS) Affects Rotational Strategy Timing (öffnet in neuem Tab)

  Stock Traders Daily · 24.09.2026

• Viatris (VTRS) Short Interest & Short Float | Updated Sep 2026 $VTRS (öffnet in neuem Tab)

  marketbeat.com · 24.09.2026

• Oppenheimer Says Viatris Looks Mispriced As Just A Generics Play (öffnet in neuem Tab)

  Finimize · 23.09.2026

• Viatris Price Target Announced at $25.00/Share by Oppenheimer (öffnet in neuem Tab)

  Moomoo · 23.09.2026

• Oppenheimer initiates Viatris stock with outperform rating (öffnet in neuem Tab)

  Investing.com · 23.09.2026

• Oppenheimer Initiates Viatris at Outperform With $25 Price Target (öffnet in neuem Tab)

  Yahoo Finance · 23.09.2026

• Viatris (VTRS) Institutional Ownership 2026 $VTRS (öffnet in neuem Tab)

  marketbeat.com · 23.09.2026

• Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business? (öffnet in neuem Tab)

  Yahoo Finance · 20.09.2026

• Viatris (VTRS) Gains Japan WAKIX Approval As Fair Value Still Sits Higher (öffnet in neuem Tab)

  Simply Wall Street · 19.09.2026

• Viatris Stock Price Forecast. Should You Buy VTRS? (öffnet in neuem Tab)

  StockInvest.us · 18.09.2026

• Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy (öffnet in neuem Tab)

  Yahoo · 17.09.2026

• Could Japan Sleep Drug Approval Alter The Investment Case For Viatris (VTRS)? (öffnet in neuem Tab)

  Simply Wall Street · 16.09.2026